Penn Vet | Clinical Trial Detail - DIABETES - Validation of the FreeStyle Libre flash glucose monitor in dogs and cats with diabetes mellitus
Contact
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
610-444-5800
Directions
Ryan Hospital Philadelphia, PA
Emergencies:
215-746-8911
Appointments:
215-746-8387
Directions

DIABETES - Validation of the FreeStyle Libre flash glucose monitor in dogs and cats with diabetes mellitus

Jun 26, 2018

The FreeStyle Libre 14 day (FSL) flash glucose monitoring system is FDA approved for humans and is an affordable system that is factory calibrated and measures interstitial glucose concentrations every minute, thus providing advantages over the traditional blood glucose curves.

The FSL system also allows monitoring of blood glucose at home, without the need for blood withdrawal. The sensor is easy to place (no sedation is required) and appears to be well tolerated by patients.

The primary aim of this study is to validate the FSL glucose monitoring system for the use in dogs and cats with diabetes. 

Eligibility:  

  • All diabetic dogs and cats, both inpatients and outpatients can be included in the study.
  • This study will require three separate blood glucose curves performed within a two-week period (day 0, day 6-7, day 12-13).
  • These blood curves will be performed free of charge. However, owners will be required to purchase a disposable sensor (about $30-40) and recorder (about $80-90). The reorder will be kept by the owner for use with future sensors. 

Contact:

Please contact Drs. Shea (emshea@upenn.edu) or Hess for further information (rhess@upenn.edu).